Alnylam Pharmaceuticals
ALNY
#554
Rank
NZ$75.62 B
Marketcap
NZ$570.22
Share price
0.17%
Change (1 day)
29.77%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company